Analytical Data
-
基因名
ND75
- Application
-
别名
Complex I-75kD Short name: CI-75kD
-
种属
Drosophila melanogaster
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q94511
-
表达区间
28-315aa
-
分子量
47.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ND75 recombinant protein is derived from the ND75 gene, which plays a crucial role in various cellular processes, particularly in the regulation of mitochondrial function and energy metabolism. Research into ND75 has gained traction due to its potential implications in cellular respiration, oxidative stress response, and signaling pathways associated with mitochondrial health. Studies have suggested that abnormalities in ND75 may be linked to several metabolic disorders and neurodegenerative diseases, such as Parkinson's and Alzheimer's, highlighting the importance of understanding its biological functions. The recombinant form of ND75 allows for detailed investigation of its structure and function, enabling researchers to elucidate its role in mitochondrial dynamics and explore its potential as a therapeutic target. Moreover, the development of ND75 recombinant protein opens avenues for high-throughput screening of small molecules that could modulate its activity, thus providing a promising approach for drug discovery aimed at treating diseases connected to mitochondrial dysfunction. As research progresses, the characterization of ND75 and its interactions with other mitochondrial proteins may offer insights into innovative strategies for managing mitochondrial-related disorders and enhancing cellular energy production.












